Merck Merges With Schering-Plough
Published: 04-Nov-2009
The new Merck's expanded portfolio also includes products from its Animal Health and Consumer Health Care business units
Merck & Co has outlined its global plans after Merk's merger with Schering-Plough. The new Merck will be a global health care leader aimed at providing innovative, distinctive products and services that save and improve lives, while satisfying customer needs and creating long term shareholder value.
By leveraging Merck's expanded product offerings, the new company expects to benefit from additional revenue growth opportunities. Merck will pursue expanded life-cycle management through the introduction of potential new combinations and formulations of existing products.
The new Merck's diverse portfolio of adult, adolescent and pediatric vaccines and medicines spans important therapeutic areas, including cardiovascular, diabetes, obesity, bone, respiratory, immunology, dermatology, infectious disease, oncology, neurosciences, ophthalmology, women’s health and endocrinology.
The new Merck's expanded portfolio also includes products from its Animal Health and Consumer Health Care business units.
The organizational structure is expected to take advantage of the combined strengths of Merck and Schering-Plough to create a more customer-focused, innovative, and diversified global health care company positioned to capitalize on the company’s greatest opportunities for growth, particularly in emerging markets, biologics and vaccines.
Richard Clark, chairman, president and chief executive officer of Merck, said: “With our merger now complete, we are ready to deliver on the promise of a new Merck built on a foundation of scientific innovation and dedication to the well-being of patients around the world.
"Our integration teams prepared us well for a strong start, with thorough plans designed to ensure a seamless transition for our customers and employees. The combination of the considerable talents of Schering-Plough and Merck employees across the globe positions Merck to move through this dynamic time for our industry with a clear vision for the future."
Network Sites

Suppliers To This Sector
Browse A-Z
World Courier
Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...
WebWise Learning
Turning Information into Working Knowledge ...
Vetter Pharma International
High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...
Valsynthese
Hazardous Chemistry in Safe Hands ...
USB
Products from Affymetrix ...
Umicore Precious Metals Chemistry
Chemicals and Catalysts for Industrial Applications ...
White Papers
Browse A-Z
Your IP at Risk in Collaborations!
Free white paper: Ten steps to protect your R&D investment within partnerships. ...
Why, When and How to Conduct 14C Human Studies
Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...
Why CAPA Still Matters
This free white paper explores the needs and effectiveness of correct CAPA control, how to ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly
Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...


Delicious
Digg
Reddit
Stumble
LinkedIn
Mail sent successfully